Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

A potential massive breakthrough!

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

The World Health Organization (WHO) today announced recommendations for the viral composition of influenza (or "flu") vaccines for the 2026-2027 northern hemisphere influenza season. The announcement ...

Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.

COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...